Inclusion Criteria (PTA group)
  -  T1D patients who received their first PTA, or second PTA only if their first graft was explanted within a week, between 2 January 2005 and 31 December 2017
  -  age ≥18 and < 65 years
  -  willingness to participate in this observational study
Inclusion Criteria (control group)
  -  Type 1 diabetes
  -  age ≥18 years and < 65 years
  -  willingness to participate in this observational study
  -  minimum disease duration of 5 years
  -  brittle diabetes, as defined by the occurrence of frequent acute complications (ketoacidosis or severe hypoglycaemic episodes requiring third-part assistance or unawareness despite well-conducted intensive insulin therapy)
  -  presence of at least one diabetes-related complication (either neuropathy, retinopathy, subclinical nephropathy).
Exclusion Criteria (both groups)
  -  conditions other than T1D known to affect bone health (i.e., non-compensated hypothyroidism, hyperthyroidism, hyperparathyroidism, inflammatory bowel disease, malignancy, rheumatoid arthritis, hypogonadism, severe chronic obstructive pulmonary disease, hepatic insufficiency, alcohol intake ≥ 3 units/day ),
  -  use of drugs that can affect bone metabolism (e.g., bisphosphonates, anticonvulsants, hormone replacement therapy) other than glucocorticoids and immunosuppressants
  -  recipients of simultaneous pancreas kidney transplantation, pancreatic islet transplantation, multiple PTAs, other transplants
  -  BMI <18.5 or ≥ 30 kg/m2